Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 4:21 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1345–1368 of 1,807 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Implanted Device Clear all

Conditions: Right Bundle-Branch Block, Heart Failure, His-bundle Pacing, Cardiac Resynchronization Therapy
Interventions: His-CRT implantation, BIV-CRT implantation; Procedure
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 14
States / cities: Phoenix, Arizona • Los Angeles, California • Tampa, Florida + 8 more

Conditions: Kidney Disease, Kidney Failure, Chronic Kidney Disease
Interventions: Surgical fistula creation from patient's anatomy, Surgical Graft implant; Procedure · Device
Lead sponsor: E. Peden, MD; Other
Eligibility: 70 Years and older
Enrollment: 270 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2025
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Urinary Incontinence
Interventions: ProACT (Adjustable Continence Therapy); Device
Lead sponsor: Uromedica; Industry
Eligibility: 45 Years and older · Male only
Enrollment: 123 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2017
U.S. locations: 7
States / cities: Tucson, Arizona • Los Angeles, California • Pembroke Pines, Florida + 4 more

Conditions: Treatment of Patients Suffering From Overactive Bladder (OAB)
Interventions: RENOVA iStim™ System; Device
Lead sponsor: BlueWind Medical; Industry
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 282 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 14
States / cities: Orange, California • San Diego, California • Norwalk, Connecticut + 11 more

Conditions: Trauma, Tumor, Pseudarthrosis, Scoliosis, Degenerative Disc Disease
Interventions: VueLock™ Anterior Cervical Plate; Device
Lead sponsor: Zimmer Biomet; Industry
Eligibility: Not listed
Enrollment: 371 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2009
U.S. locations: 4
States / cities: Palo Alto, California • San Diego, California • Avon, Indiana + 1 more

Conditions: PTSD, Post Traumatic Stress Disorder
Interventions: Active VNS stimulation, Sham VNS stimulation; Device
Lead sponsor: The University of Texas at Dallas; Other
Eligibility: 22 Years to 79 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 3
States / cities: Austin, Texas • Dallas, Texas • Richardson, Texas

Conditions: Type 1 Diabetes Mellitus
Interventions: Sernova Cell Pouch; Combination Product
Lead sponsor: Sernova Biotherapeutics Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Epiphora, Dacryocystorhinostomy
Interventions: Slit Stent II, BIKA for DCR; Device
Lead sponsor: Thomas Gardner; Other
Eligibility: 22 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Acute Myocardial Infarction, Pacing Therapy, Cardiac Remodeling, Heart Failure
Interventions: Single Site Pacing, Dual Site Pacing; Device
Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure; Industry
Eligibility: 18 Years and older
Enrollment: 129 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2016
U.S. locations: 17
States / cities: Scottsdale, Arizona • Los Angeles, California • Atlanta, Georgia + 14 more

Conditions: Kidney Failure, Chronic, Renal Dialysis
Interventions: InnAVasc arteriovenous graft surgical implant; Device
Lead sponsor: W.L.Gore & Associates; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 7
States / cities: San Diego, California • Flint, Michigan • Greenwood, Mississippi + 4 more

Conditions: Treatment Resistant Depression
Interventions: Vagus Nerve Stimulation; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Stanford, California

Conditions: Contraception
Interventions: Paragard® T380A Intrauterine Copper Contraceptive with New Inserter; Combination Product
Lead sponsor: CooperSurgical Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 119 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 8
States / cities: Denver, Colorado • South Miami, Florida • Atlanta, Georgia + 4 more

Conditions: Pain, Postoperative
Interventions: Bupivacaine Collagen Sponge, Placebo; Drug
Lead sponsor: Innocoll; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Albany, New York

Conditions: Aphakia, Presbyopia
Interventions: CPO Pro IOL, CPO IOL, Cataract Surgery; Device · Procedure
Lead sponsor: Alcon Research; Industry
Eligibility: 22 Years and older
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 8
States / cities: Torrance, California • Bloomfield Hills, Michigan • Kansas City, Missouri + 5 more

Conditions: Parkinson Disease
Interventions: Levodopa, Clinical DBS Setting, Sham DBS, DBS Setting Maximizing Prefrontal Activation, DBS Setting Minimizing Prefrontal Activation; Drug · Device
Lead sponsor: Emory University; Other
Eligibility: 45 Years to 75 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2027
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Pulmonary Regurgitation
Interventions: Transcatheter pulmonary valve implantation (TPVI), VenusP-ValveTM System; Device
Lead sponsor: Venus MedTech (HangZhou) Inc.; Industry
Eligibility: 12 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2034
U.S. locations: 1
States / cities: Irvine, California

Conditions: Cataract, Presbyopia
Interventions: IC-8 IOL Group, Control Group; Device
Lead sponsor: AcuFocus, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 453 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 21
States / cities: Tucson, Arizona • Bakersfield, California • Laguna Hills, California + 18 more

Conditions: Vestibular Schwannoma, Meniere Disease
Interventions: Cochlear Implant; Device
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Pancreatic Cancer
Interventions: cetuximab, capecitabine, docetaxel, Erlotinib, Gemcitabine, Irinotecan, mitomycin C, rapamycin, conventional surgery; Biological · Drug · Procedure
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years to 120 Years
Enrollment: 249 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Patent Foramen Ovale, Cardiac Implantable Electronic Device
Interventions: Apixaban, Placebo; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 85 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Painful Bladder Syndrome, Interstitial Cystitis, Pelvic Floor; Insufficiency, Bowel Dysfunction, Sexual Dysfunction, Pelvic Floor; Incompetency
Interventions: Changing the Interstim parameter of '' Frequency" in patients with Interstitial Cystitis; Other
Lead sponsor: Pelvic and Sexual Health Institute; Other
Eligibility: 18 Years to 70 Years · Female only
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2018
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Retinitis Pigmentosa
Interventions: Argus II; Device
Lead sponsor: University of California, Santa Barbara; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 3
States / cities: Santa Barbara, California • Baltimore, Maryland • Ann Arbor, Michigan

Conditions: Hearing Loss
Interventions: Vibrant Soundbridge; Device
Lead sponsor: Med-El Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2014
U.S. locations: 11
States / cities: Los Angeles, California • San Jose, California • Miami, Florida + 8 more

Conditions: Heart Failure, Hypertension
Interventions: Not listed
Lead sponsor: Baxter Healthcare Corporation; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 109 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: Imperial, California

Search by objective public record fields.

His-Bundle Corrective Pacing in Heart Failure

Hemodialysis in the Elderly (70yrs & Older)

ProACT Therapy for the Treatment of Stress Urinary Incontinence in Males

BlueWind RENOVA iStim™ System for the Treatment of OAB

Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System

Targeted Plasticity Therapy for PTSD

A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch™ for Clinical Islet Transplantation

SLlt Stent II Lacrimal Stent for the Treatment of Nasolacrimal Duct Obstruction

Post-Myocardial Infarction Remodeling Prevention Therapy

Evaluating the Safety and Effectiveness of the InnAVasc Graft for Dialysis Access in Patients With Kidney Failure

Vagus Nerve Stimulation (VNS) Electroencephalogram (EEG) Protocol Supplement

A Study to Assess the Safety of a New Inserter Device for Paragard® (Intrauterine Copper Contraceptive)

Efficacy and Safety of A Collagen Bupivacaine Implant in Patients After Gastrointestinal Surgery

Clareon PanOptix Pro vs. Clareon PanOptix - Study B

Cortical Electrophysiology of Response Inhibition in Parkinson's Disease

VenusP-Valve Pivotal Study (PROTEUS STUDY)

Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens

CI Following VS Removal or Labyrinthectomy

Individualized Drug Treatment for Treating Patients With Pancreatic Cancer

Patients With Patent Foramen Ovale and Endocardial Device Leads on Apixaban for Prevention of Paradoxical Emboli

Clinical Efficacy of Changing the InterStim® Parameters in Patients With Interstitial Cystitis/Painful Bladder Syndrome

The Perceptual Experience of Argus II Users

Safety and Efficacy of the Vibrant Soundbridge (VSB) for Mixed and Conductive Hearing Losses

Necklace-Shaped Sensor for Non-Invasive Remote Monitoring of Vitals